Navigation Links
Somanetics Reports Financial Results for the Third Quarter of Fiscal 2009
Date:9/17/2009

approximately 86 percent and operating margin of approximately 20 percent.

  • Fiscal 2009 income before income taxes in the range of $11.2 million to $11.6 million.

Current estimates are based on market and economic conditions, including the assumption that the current economic downturn continues throughout fiscal 2009, and Somanetics' current plans to invest in several areas of its business. Such investments include clinical research, medical education, research and development projects, the continued development and market launch of the Vital Sync System and the addition of sales and clinical education personnel in the U.S. and international markets. Somanetics undertakes no obligation to update its estimates.

Somanetics to Host Conference Call

Somanetics will webcast its third quarter 2009 conference call at 10:00 a.m. (ET) today. To join the webcast, visit the Presentations & Webcasts page in the Investor Relations section of Somanetics' website at www.somanetics.com and click on the "Q3 2009 Somanetics Corporation Earnings Conference Call" link. The call also will be archived on the website.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS((R)) Cerebral/Somatic Oximeter which noninvasively provides accurate, real-time blood oxygen measurements in patients greater than 2.5 kilograms, and trend monitoring of this parameter for individuals of any weight. The INVOS System is the only commercially-available cerebral/somatic oximeter proven to improve outcomes. Surgeons, anesthesiologists and other medical professio
'/>"/>

SOURCE Somanetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien
2. Somanetics Corporation to Release Second Quarter 2009 Financial Results and Host Conference Call June 17, 2009
3. 25 Clinical Abstracts at National Conference Spotlight Clinical Utility of Somanetics INVOS System in Neonates
4. Somanetics Announces New FDA 510(K) Clearance
5. Somanetics Reports Record Net Revenues and Income Before Income Taxes for Fourth Quarter and Fiscal 2008
6. Somanetics Corporation to Release Fourth Quarter and Fiscal 2008 Financial Results and Host Conference Call January 21, 2009
7. Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
8. Somanetics Announces Share Repurchase Program Increased By $15 Million
9. Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
10. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
11. Somanetics Announces Share Repurchase Program Increased by $15 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 The age spots, wrinkles ... over the age of 30 are now explored in a ... the best eye creams for women over 30 are introduced ... http://cherrynews.com/best-nourishing-eye-serum . , The use of creams as an ... partly based on cost, according to the information in the ...
(Date:7/23/2014)... Edmond, Oklahoma (PRWEB) July 23, 2014 ... North America’s leading provider of in-home care for ... Healthy Longevity Webinar Series featuring experts in a ... upcoming webinar will feature licensed clinical social worker ... the most common causes of caregiver stress and ...
(Date:7/23/2014)... NY, July 24, 2014) If past experience is ... State are about to get a lot more recognition ... already on the books allowing NPs to provide primary ... patient care and better relationships with physicians and administrators, ... study from Columbia University School of Nursing, published in ...
(Date:7/23/2014)... Celebrating a decade of philanthropy in 2014, ... awarding of $1,070,000 in grants to 20 New Jersey ... the Foundation’s 1,000th grant. , “The Horizon Foundation for ... supporting community-based organizations that are working to improve public ... Garden State,” said Robert A. Marino, Horizon Blue Cross ...
(Date:7/23/2014)... growing body of research suggesting a safe and ... postmenopausal breast cancer, with fewer detrimental side effects ... therapies. The study will be published in final ... Biology and Endocrinology . , Breast cancer is ... the United States. Approximately 70% of breast cancers ...
Breaking Medicine News(10 mins):Health News:Best Eye Creams for Women Over 30 Detailed in Published Guide at News Website Online 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:New York law offers nurses more recognition, responsibility 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5
... MINNEAPOLIS, Oct. 17 Health Fitness Corp.,(OTC Bulletin Board: ... results for the third quarter ended September 30,2007, on ... Company also,announced that it will hold a conference call ... call will be Dr. Gregg Lehman, President and,Chief Executive ...
... Fla., Oct. 17 "As a physician,you hear all ... says Dr. Terry,D. Hashey, Medical Director of First Coast ... Corral Flu Campaign.,The most common that Dr. Hashey reports ... the flu shot. "That couldn,t be farther from the ...
... outcomes at Houston Northwest Medical ... nation,s best for several service lines, HOUSTON, ... Hospital Quality in America Study issued today, Houston,Northwest ... service,lines including overall gastrointestinal services, gastrointestinal,surgery, stroke, general ...
... that hospital-caused MRSA infections are about triple, previous estimates. The Centers ... and have failed to call on hospitals to take the ... ... infections., NEW YORK, Oct. 17 Today, data in an article,published ...
... WEST CHESTER, Ohio, Oct. 16 AtriCure, Inc.,(Nasdaq: ... leader in cardiac surgical,ablation products, today announced that ... which physicians have adopted to,treat atrial fibrillation (AF), ... Dr. James H. McClelland, an,electrophysiologist, and colleagues from ...
... breast cancer drugs called taxanes, which include Taxol (paclitaxel) ... part of chemotherapy following surgery for cancers that have ... research. , The review, which compared chemotherapy regimes ... studies including 21,191 women. , For patients, this study ...
Cached Medicine News:Health News:Health Fitness Corp. to Report Third Quarter 2007 Financial Results on November 5, 2007 2Health News:Flu Myths Abound in Flu Season 2Health News:Houston Northwest Medical Center's Patient Outcomes Superior 2Health News:Houston Northwest Medical Center's Patient Outcomes Superior 3Health News:The Journal of the American Medical Association (JAMA) Article Reveals Scope of MRSA Infections 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3Health News:Taxol-type drugs give slight boost to survival rates in early breast cancer 2Health News:Taxol-type drugs give slight boost to survival rates in early breast cancer 3
(Date:7/23/2014)... 23, 2014  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: ... on its expertise in opioid antagonists, announced today ... application ("IND") with respect to its naloxone-based opioid ... that it has received an additional commitment from ... of the National Institutes of Health ("NIH"), to ...
(Date:7/23/2014)... , July 23, 2014  Silk Road Medical, ... transcarotid treatment of intra- and extra-cranial cerebrovascular disease, ... Wallace to the position of Chief Technology ... the company,s Research and Development efforts across its ... Prior to joining Silk Road Medical, ...
(Date:7/23/2014)... 2014  ACON Equity Partners III, L.P., a private ... announced it has completed the purchase of Injured Workers ... and Parthenon Capital Partners. IWP is a leading specialty ... Automobile Personal Injury Protection and Personal Injury pharmacy markets ... As part of this transaction, ACON partnered ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3ACON Investments Acquires Injured Workers Pharmacy 2ACON Investments Acquires Injured Workers Pharmacy 3
... Jan. 16, 2012 Boston Scientific Corporation (NYSE: ... its ORION trial, demonstrating excellent outcomes for the Company,s ... artery disease, a form of peripheral artery disease associated ... Results were presented today by Daniel Clair, M.D., FACS, ...
... SAN FRANCISCO, Jan. 16, 2012 Dicom Systems ( ... is pleased to announce their selection as the Vendor ... California-based full service physician-owned teleradiology group. ... you have the capacity to turn your current storage ...
Cached Medicine Technology:Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 2Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 4Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 5ONRAD, Inc. Chooses Dicom Systems' Vendor Neutral Archive 2
... supports interventional cardioangiography procedures with MR imaging ... cardioangiography system., Utilize your angio and MR ... our integrated suite. Because the systems can ... diagnosis and follow-up in one room, one ...
... a comprehensive medical billing software capable ... multiple payer requirements of healthcare billing ... functionality to necessary to process claims ... such as trip reporting for ambulance ...
... code the charge while completing a chart note, ... from office, both directly feeding the charge entry ... Form/Superbill, data entry can be done with our ... are posted by reflecting open item charges, and ...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
Medicine Products: